GILD vs JNJ: Side-by-Side Comparison
Compare Gilead Sciences Inc (GILD) and Johnson & Johnson (JNJ) side by side: market cap USD 162.98B vs USD 633.19B, P/E 17.9 vs 30.4. Financials, growth and model signals on Bullrun.
| Metric | GILD | JNJ |
|---|---|---|
| Company | Gilead Sciences Inc | Johnson & Johnson |
| Country / Exchange | United States · NASDAQ | United States · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-General | Drug Manufacturers-General |
| Market cap | USD 162.98B | USD 633.19B |
| P/E ratio | 17.9 | 30.4 |
| Dividend yield | 2.45% | 1.99% |
| Valuation model | 9.2% undervalued | 3.0% undervalued |
| Revenue (FY2025) | USD 29.44B | USD 94.19B |
| Revenue growth YoY | +2.4% | +6.0% |
| Net income | USD 8.51B | USD 26.80B |
| Gross margin | 78.8% | 67.9% |
| Diluted EPS | 6.78 | 11.03 |